Package 43066-142-10

Brand: naloxone hydrochloride

Generic: naloxone hydrochloride
NDC Package

Package Facts

Identity

Package NDC 43066-142-10
Digits Only 4306614210
Product NDC 43066-142
Product ID 43066-142_48137634-91d7-41e3-b54b-e4321d69668a
Description

10 CARTON in 1 CARTON (43066-142-10) / 1 SYRINGE, GLASS in 1 CARTON (43066-142-01) / 2 mL in 1 SYRINGE, GLASS

Marketing

Marketing Status
Marketed Since 2025-06-03
Brand naloxone hydrochloride
Generic naloxone hydrochloride
Sample Package No

Linked Drug Pages (1)

naloxone hydrochloride ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAMUSCULAR", "INTRAVENOUS", "SUBCUTANEOUS"], "spl_id": "48137634-91d7-41e3-b54b-e4321d69668a", "openfda": {"unii": ["F850569PQR"], "rxcui": ["1191250"], "spl_set_id": ["48137634-91d7-41e3-b54b-e4321d69668a"], "manufacturer_name": ["Baxter Healthcare Corporation"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "10 CARTON in 1 CARTON (43066-142-10)  / 1 SYRINGE, GLASS in 1 CARTON (43066-142-01)  / 2 mL in 1 SYRINGE, GLASS", "package_ndc": "43066-142-10", "marketing_start_date": "20250603"}], "brand_name": "naloxone hydrochloride", "product_id": "43066-142_48137634-91d7-41e3-b54b-e4321d69668a", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Opioid Antagonist [EPC]", "Opioid Antagonists [MoA]"], "product_ndc": "43066-142", "generic_name": "naloxone hydrochloride", "labeler_name": "Baxter Healthcare Corporation", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "naloxone hydrochloride", "active_ingredients": [{"name": "NALOXONE HYDROCHLORIDE", "strength": "1 mg/mL"}], "application_number": "ANDA214785", "marketing_category": "ANDA", "marketing_start_date": "20250603", "listing_expiration_date": "20261231"}